|
1. Wada Y, Nakamura Y, Koshiyama H. Lack
of positive correlation between statin use and bone mineral density in
Japanese subjects with type 2 diabetes (letter). Arch Intern Med 2000;
160:2865.
2. Koshiyama H, Wada Y, Nakamura Y. Hypercholesterolemia as a possible
risk factor for osteopenia in type 2 diabetes (letter). Arch Intern Med
2001; 161:1678.
3. Honjo S, Nishi Y, Wada Y, Hamamoto Y, Koshiyama H. Possible beneficial
effect of telmisartan on glycemic control in diabetic subjects (letter).
Diabetes Care 2005;28(7):498.
4. Koshiyama H, Honjo S, Hamamoto Y, Ikeda H, Wada Y. Drugs share antidiabetic
and antiatherosclerotic actions though gthe common soil.h @Medical Hypotheses
2006;66(3):473-475.
5. Koshiyama H, Honjo S, Hamamoto Y, Wada Y, Ikeda H. Hypothalamic pathogenesis
of type 2 diabetes. Medical Hypotheses 2006; 67:307-310.
6. Nabe K, Honjo S, Ikeda H, Wada Y, Nomura K, Hamamoto Y, Koh T, Tatsuoka
Y, Koshiyama H. Diabetes insipidus and cognitive function. Medical Hypotheses
2007; 69:764-766.
7. Arai K, Nabe K, Ikeda H, Honjo S, Wada Y, Hamamoto Y, Nomura K, Aoki
T, Sano T, Koshiyama H. A case of lymphocytic panhypophysitis during pregnancy.
Endocrine 2007;32(1):117-121.
8. Nabe K, Nomura K, Ikeda H, Honjo S, Wada Y, Kimura T, Aoyama T, Hamamoto
Y, Koshiyama H. Depression is one component of metabolic syndrome. Medical
Hypotheses Research 2008;4(2):79-83.
9. Ikeda H, Nakamura Y, Minamikawa J, Honjo S, Hamamoto Y, Wada Y, Nabe
K, Koshiyama H. Comparison of Effects of Amlodipine and Angiotensin Receptor
Blockers on the Intima-media Thickness of Carotid Arterial Wall (AAA Study:
Amlodipine vs ARB in Atherosclerosis Study) Diabetes Res Clin Pract 2009;
83:117-118.
10. Ikeda H, Honjo S, Hamamoto Y, Wada Y, Nabe K, Koshiyama H. Olmesartan
reduced microalbuminuria in Japanese subjects with type 2 diabetes. (leter).
Diabetes Res Clin Pract 2009; 83: 50-53.
|